Plasma-membrane fractions were prepared from the livers of rats injected with 0.15 M-NaCl (controls) or vasopressin (1 nmol/kg body wt.). When assayed in the presence of deoxycholate, vasopressin increased the V0,ax of plasma-membrane diacylglycerol kinase 2-4-fold, and the apparent K", of the enzyme for 1,2-dioleoyl-sn-glycerol was doubled. The effect of vasopressin on the Vmax of plasma-membrane diacylglycerol kinase was twice as great between pH 7 and 8.5 than at pH 6 or 6.5. Vasopressin doubled the activity of diacylglycerol kinase in the plasma-membrane fraction when the enzyme was assayed with phosphatidylserine rather than deoxycholate as stimulator, and when either I -stearoyl-2-arachidonoyl-sn-glycerol or 1,2-dioleoyl-sn-glycerol was the substrate. In perfused livers vasopressin (10 nM) increased the Vmax. of plasmamembrane diacylglycerol kinase 2-fold, and phenylephrine (3 /tM) gave a similar effect. Vasopressin doubled diacylglycerol kinase activity in hepatocytes that had been preincubated for 55 min, but not in cells that had only been preincubated for 15 min.
INTRODUCTION
Vasopressin and other Ca2"-mobilizing hormones stimulate phosphatidylinositol turnover in the liver. The hormone-stimulated breakdown of phosphatidylinositol 4,5-bisphosphate involves the G-protein-mediated activation of a membrane-associated phospholipase C [1, 2] . This in turn leads to the generation of two potential second messengers, namely inositol 1,4,5-trisphosphate, which mobilizes Ca2" from stores in the endoplasmic reticulum, and diacylglycerol (DAG) , which activates protein kinase C [3] [4] [5] .
DAG activates protein kinase C by increasing its affinity for Ca2" and promoting the translocation of the enzyme from the cytosol to the plasma membranes [6] . DAG kinase (EC 2.7.1.107) catalyses the formation of phosphatidic acid from DAG and ATP, and could be an important factor in controlling the concentration of DAG in the membranes and hence protein kinase C activation. Indeed, in platelets, DAG analogues, which inhibit DAG kinase activity in vitro, lead to a longerlasting DAG signal in cells stimulated by thrombin [7] , and another DAG kinase inhibitor, R59022, potentiates protein kinase C activation by thrombin in these cells [8] . DAG kinase belongs to the so-called 'ambiquitous' family of enzymes. Its activity is distributed between soluble and particulate fractions, and in rat liver approx. 5000 of the activity recovered from the initial homogenate is found in the soluble fraction and 3000 in microsomal fractions (microsomes) [9] . Both soluble and microsomal DAG kinase have similar specific activities and Km1 values for DAG and ATP [9] . Translocation of the enzyme from cytosol to membranes has been observed in rat brain and rat liver homogenates incubated with phospholipase C or DAG [101 and in neutrophils treated with-chemotactic peptide or phorbol ester [11 ] . Recently DAG kinase has been purified to homogeneity from pig [12] and rat [10] brain cytosol, and polyclonal antibody raised against the pig brain soluble enzyme precipitated the soluble, microsomal and synaptosomal activities [13] , suggesting that one form of enzyme is present in all three fractions.
A detailed study of plasma-membrane DAG kinase has not been undertaken to our knowledge. Since the pool of DAG in the plasma membrane is of prime importance for protein kinase C activation, we have studied some properties of DAG kinase in plasma membranes isolated from rat liver. We report that vasopressin activates rat liver plasma-membrane DAG kinase in vivo, in the perfused liver and in hepatocytes incubated in vitro. In addition, phenylephrine was found to activate plasma-membrane DAG kinase in perfused livers.
MATERIALS AND METHODS

Materials
Fed male Wistar rats weighing 180-200 g were used throughout. Percoll was from Pharmacia, Uppsala, Sweden. 1,2-Dioleoyl-sn-glycerol, I-stearoyl-2-arachidonoyl-sn-glycerol, vasopressin, phosphatidylserine and phosphatidate (from egg-yolk lecithin) were from Sigma, St Vol. 255 body wt.). After 5 min, a portion of liver (about 3 g) was rapidly excised, minced and homogenized in 8 vol.
(v/w) of 0.25 M-sucrose/20 mM-KF/2 mM-EGTA/5 mm-EDTA/1 mM-dithioerythritol/ 10 mM-Tris/HCl, pH 7.4 (sucrose buffer), at 0°C with a Potter-Elvehjem homogenizer. Plasma membranes were then prepared as described below.
Rat livers were perfused in situ as previously described [14] with Krebs-Henseleit buffer containing 10 mMglucose. After 10 min, 0.15 M-NaCJ (controls), vasopressin (10 nM) or phenylephrine (3 /,M) was added to the perfusion medium and perfusion was continued for 10 min. Approx. 3 g of liver was then excised and homogenized as described above.
Rat hepatocytes were prepared [15] for 15 min) and washed once in 10 ml of saline buffer. The washing removed Percoll from the plasmamembrane fraction. Finally the plasma membranes were collected by centrifugation and resuspended (Teflon/ glass hand-powered homogenizer at a protein concentration of 2-3 mg/ml) in sucrose buffer (which prevented the aggregation of membranes observed in saline buffer).
For phosphorylase assay a sample of 27 500 g supernatant was taken, and in some experiments the whole supernatant was centrifuged at 105000 g for I h to prepare microsomal and soluble fractions. DAG kinase assay DAG kinase was assayed at 30°C in 0.5 ml of 100 mMTris/HCI/20 mM-NaF/ 1 mM-dithioerythritol, pH 7. [9].
The assays were performed in the presence and the absence of exogenously added DAG, and the DAGindependent rates of incorporation of radioactivity into chloroform-soluble reaction products were subtracted from the total rates of incorporation (with added DAG) to correct for the presence of endogenous DAG in the membranes and for the presence of other lipid kinases such as phosphatidylinositol kinases. The incorporation of 32P into chloroform-soluble products was linear up to at least 20 min in the presence and the absence of added diolein, when I mg of deoxycholate/ml (Fig. 1) or 0.5 mg of phosphatidylserine/ml was included to stimulate DAG kinase (not shown). In plasma membranes from control rats, added DAG increased the incorporation of 32P into chloroform-soluble products 2-3-fold when deoxycholate was present (Fig. 1) . Vasopressin treatment did not affect the DAG-independent rate ofincorporation of radioactivity into chloroform-soluble products, but caused a 2-fold increase in the total rate of incorporation of 32P into chloroform-soluble products compared with the control (Fig. 1) . When microsomes were prepared from the 27500 g supernatant as described above and assayed under identical conditions, added dioleoylglycerol caused an 8-1 0-fold stimulation of 32P incorporation into lipid products compared with the rate observed in the presence of deoxycholate alone (results not shown). These findjings are in agreement with the results of Kanoh & Akesson [9] , who observed a similar stimulation of the reaction rate by dioleoylglycerol.
To identify the reaction product, a sample of the chloroform layer was taken, evaporated to dryness under N2, and 50-100 ,ug of carrier phosphatidate was added to the residue. Lipids were separated by t.l.c. on silicagel 60 F-254 plates with chloroform/methanol/NH3 (12: 6: 1, by vol.) as solvent, and identified with 12 vapour. The spot corresponding to authentic phosphatidate was cut out and its radioactivity was counted. These studies showed that 8000 and 3400 of the chloroform-soluble 32p was incorporated into phosphatidate (R,. = 0.25) in the presence and the absence of exogenous diolein respectively. Moreover, in plasma membranes from vasopressin-treated rats the incorporation of 32p into the phosphatidate spot was increased 2-fold. Plasmamembrane DAG kinase activities were sometimes expressed as pmol of phosphatidate formed per munit of 5'-nucleotidase to correct for differences in homogenization and recovery. Other assays Glutamate dehydrogenase [16] , lactate dehydrogenase [17] , NADP+-cytochrome c reductase [18] , phosphorylase a [14] and 5'-nucleotidase [19] activities were measured as described in the references. One unit of enzyme activity is the amount of enzyme which catalyses the formation of I ,umol of product/min under the stated conditions. Protein was measured as described by Bradford [20] , with bovine serum albumin as standard.
RESULTS AND DISCUSSION
Effect of vasopressin on plasma-membrane DAG kinase activity in vivo Table 1 shows a comparison of the specific activities of DAG kinase and marker enzymes in liver homogenates and plasma-membrane fractions from control and vasopressin-treated rats. The enzyme markers were glutamate dehydrogenase (mitochondria), lactate dehydrogenase (cytosol), NADP+-cytochrome c reductase (microsomes) and 5'-nucleotidase (plasma membranes). Vasopressin treatment did not affect the specific activities of the enzyme markers or their recoveries in the plasmamembrane fraction. In addition, vasopressin had no effect on the specific activity of DAG kinase in the homogenate, but doubled the specific activity of DAG kinase in the plasma-membrane fraction and increased the recovery of the enzyme in this fraction ( Table 1 ). The specific activities of 5'-nucleotidase show that plasma membranes were purified 13-fold from the homogenate and that the recovery was 250. There was some enrichment in specific activity of the microsomal marker NADP+-cytochrome c reductase in the plasmamembrane fraction. One could argue that the presence of 20 of the total activity (Table 1 ). Fig. 2 shows the effect of vasopressin on the saturation curves of plasma-membrane DAG kinase for 1,2-dioleoyl-sn-glycerol. The Vmax values calculated by computer fitting [21] of the data in Fig. 2 were approximately doubled, and in addition the calculated apparent Km for 1,2-dioleoyl-sn-glycerol was increased from 0.02 mg/ml for the controls to 0.04 mg/ml for the DAG kinase activity of plasma membranes from rats treated with vasopressin. Therefore, since the Km is doubled together with a doubling of Vmax., no change in actual rate would result if the substrate concentration remained unchanged in the Km range. However, the hormone-stimulated breakdown of phosphatidylinositol phosphates probably increases the plasma-membrane concentration of DAG and the main effect of vasopressin on DAG kinase is likely to be a doubling of Vmax. The inclusion of proteinase inhibitors in the homogenization medium did not affect the results, i.e. a doubling of the Vmax of DAG kinase (result not shown). In some experiments, such as those shown in Fig. 3(a) , vasopressin increased the Vmaxof DAG kinase by 4-fold. DAG vasopressin-treated (-) rats Plasma membranes from control and vasopressin-treated rats were assayed for DAG kinase with 0.3 mg of 1,2-dioleoyl-snglycerol/mi. The diolein was sonicated with 1 mg of deoxycholate/ml in Fig. 3(a>, but in Fig. 3(b) kinase activity in liver plasma membranes from controltreated rats did not change over the pH range 6-8.5. However in plasma membranes from vasopressin-treated rats, a doubling of DAG kinase activity was observed when the pH was increased from 6.5 to 7, and the effect of vasopressin was twice as great between pH 7 and 8.5 than at pH 6 or 6.5. Previous workers have assayed DAG kinase with phospholipid rather than deoxycholate [7, 12] . Fig. 3(b) shows that plasma-membrane DAG kinase was stimulated 4-6-fold by 0.5 mg of phosphatidylserine/ml. Moreover, vasopressin doubled DAG kinase activity over the range of phosphatidylserine concentrations used, but the hormone did not affect the sensitivity of the enzyme to phosphatidylserine stimulation (Fig. 3b) . The DAG kinase activities of plasma-membrane fractions from control and vasopressin-treated rats measured with 0.5 mg of phosphatidylserine/ml (Fig. 3b) were similar to those measured with 1 mg of deoxycholate/ml (Fig. 2) , which represents the optimal concentration of detergent required to stimulate plasma-membrane DAG kinase (result not shown). In addition, when phosphatidylserine was used to stimulate DAG kinase and 1-stearoyl-2-arachidonoyl-sn-glycerol was the substrate, control plasma-membrane DAG kinase activity was 0.17 + 0.04 munit/mg of protein, which was increased to 0.30 + 0.04 munit/mg of protein by vasopressin (P < 0.05, n = 4).
Effect of vasopressin on plasma-membrane DAG kinase activity in perfused livers and hepatocytes
Vasopressin doubled plasma-membrane DAG kinase activity in perfused livers as well as in vivo (Table 2 ). In livers perfused with phenylephrine, plasma-membrane DAG kinase was activated to an extent similar to that observed with vasopressin.
The activation of plasma-membrane DAG kinase by vasopressin was also obtained in hepatocytes, but only when the cells had been incubated for 55 min before addition of the hormone ( Table 2 ). The DAG kinase activities in plasma membranes of control hepatocytes preincubated for 15 min were about twice the activities in plasma membranes from the control livers in vivo or control perfused livers, and no effect of vasopressin was seen. However, in cells preincubated for 55 min, control plasma-membrane DAG kinase activity returned to basal and vasopressin doubled DAG kinase activity (Table 2) . Vasopressin increased the activity of phosphorylase both in hepatocytes that had been preincubated for 15 min and in cells preincubated for 55 min (Table 2) . Therefore the activation of DAG kinase by vasopressin cannot be related to the effect of the hormone on phosphorylase activation.
The activation of plasma-membrane DAG kinase in control hepatocytes preincubated for 15 min might have been the result of translocation of the enzyme from the cytosol to the plasma membranes during collagenase digestion. Phospholipase C, a possible contaminant of commercial preparations of collagenase, has been reported to cause the translocation of DAG kinase from the cytosol to the membranes in liver homogenates [10] . However in control perfused livers and in livers perfused with 4 units of phospholipase C (phosphatidylcholinespecific enzyme from Bacillus cereus)/ml, plasmamembrane DAG kinase was only increased from 4.6 + 1.7 (n = 8) to 5.1 + 1.3 (n = 4) pmol of phosphatidate formed/min per munit of 5'-nucleotidase (P > 0.05) respectively.
Our results show that vasopressin and phenylephrine activate plasma-membrane DAG kinase. Vasopressin and phenylephrine could have activated plasmamembrane DAG kinase by promoting the translocation of the enzyme from the cytosol to the plasma membranes or by causing a stable change in enzyme activity, such as covalent modification. It is difficult to make any conclusions as to whether vasopressin promotes translocation of DAG kinase from cytosol to the plasma membranes. An argument against a translocation mechanism is the fact that different kinetic properties of DAG kinase were observed in plasma membranes from vasopressin-treated rats (Fig. 3a) . Although the amount of DAG kinase recovered in the plasma membranes is The vasopressin-and phenylephrine-induced activation of plasma-membrane DAG kinase could eventually contribute to the replenishment of the plasma-membrane phosphoinositide pool. The activation of DAG kinase by vasopressin and phenylephrine might antagonize protein kinase C activation, since both enzymes can compete for the same ligand, namely 1-stearoyl-2-arachidonoyl-sn-glycerol, which is liberated by hormone-stimulated phosphoinositide breakdown. Indeed, in hepatocytes incubated with phenylephrine, protein kinase C does not seem to become activated [22] . However, the results of Garrison and co-workers [23] suggest that protein kinase C becomes activated in hepatocytes incubated with vasopressin.
